Welcome to the first edition of IFAH News! This newsletter will keep you up-to-date on our latest dialogues with major international bodies, provide expertise on emerging diseases and highlight major developments within the global animal health industry.
DOWNLOAD Read more
Antibiotics not only cure bacterial diseases in people, they also cure bacterial diseases in animals.
In doing so, they help us fulfil our moral obligation to the animals in our care. At the same time, for food-producing animals, antibiotics, by ensuring the animals’ health, contribute to efficient use of limited resources and help provide a safe supply of food from healthy animals. For pets they ensure a long and healthy human-animal partnership. To read more about the benefits of antibiotics.
VICH has published a leaflet about its work and role in harmonising the global processes for authorising veterinary medicines. The leaflet can be viewed on www.vichsec.org and downloaded free of charge. *VICH: Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products.
The Global Benchmarking Survey examines the interactions between industry and regulatory systems, particularly the impact of regulations on the animal health industry’s ability to be competitive and innovative. The outcome of this survey provides an invaluable wealth of information to support informed policy decisions in the continual search for best regulatory practice and opportunities for improvement.
For more detailed information on the regional reports, please contact the relevant industry association or see their websites:
Global analysis and advisory firm Oxford Analytica, supported by a group of independent experts in animal health, were commissioned by IFAH to compare international social and economic impacts of three well-documented animal health diseases: FMD, salmonella and rabies.
This white paper is intended to serve as a launch point for wider collaborative discussions with international stakeholders on what future efforts would be required to establish effective disease control and preventative activities based on their technical merits, but also to...
IssueThe Animal Health Industry is not in favour of the serialisation of veterinary medicinal products.
BackgroundIn several countries regulators tend to request a serialisation* of veterinary medicinal products because of identical requirements implemented in the human pharmaceutical sector. It would however be a disproportionate measure for the animal health sector, using an unaffordable approach to tackle close to non-existent problems in the animal health sector.
PositionThe Animal Health Industry stands aligned that the two-dimensional...
Position paper: Risk analysis process: the scientific basis for the regulation of veterinary medicines
IssueIn the interests of public health, animal health and animal welfare veterinary medicines are regulated to ensure that only safe (for animals, users, consumers and the environment) and effective products of appropriate quality are placed on the market. This process must be achieved in a proportionate and balanced way to allow society to gain the benefits that these products bring.
BackgroundAnimal health products are essential for animal welfare and make valuable contributions to society by protecting and preserving the health of animals...
Position paper: The protection of registration data for existing and new veterinary medicinal products
IFAH, the International Federation for Animal Health, supports legislation which provides effective and adequate protection of regulatory data submitted for the market approval of new and existing veterinary medicinal products (i.e. veterinary pharmaceuticals, vaccines and other animal health products) against unfair commercialisation.
IntroductionThe development and bringing to market of a new veterinary medicinal product requires the originator to conduct extensive chemical, pharmacological, toxicological and clinical research and testing,...
This educational handbook on foot-and-mouth disease is available in both French and English and can be ordered from CIRAD - firstname.lastname@example.org. IFAH holds a limited stock of English copies which can be requested from the Communications Department - email@example.com. This intiative is supported by:Read more